Latest Health News

Amplia Therapeutics reports encouraging interim results for narmafotinib in metastatic pancreatic cancer, alongside a successful capital raise and key patent allowance.

Tyranna Resources has advanced its exploration and acquisition efforts in Angola, securing a major stake in the Chinguar Gold Project and extending its lithium-caesium project tenure, supported by a solid cash position.

LTR Pharma has made significant strides towards its US market debut with ROXUS, bolstered by expert appointments and peer-reviewed clinical data validating its rapid-onset ED treatments.

Dimerix Limited reports solid progress in its Phase 3 trial for DMX-200 targeting rare kidney disease FSGS, backed by orphan drug status in Japan and a robust cash position. The company prepares to engage the FDA on new data supporting regulatory approval.

Minerals 260 Limited has expanded its Bullabulling Gold Project drilling program to 110,000 meters following strong high-grade gold intercepts, with an updated resource estimate due in December 2025. Initial metallurgical tests show gold recoveries exceeding 95%, bolstering project economics as the pre-feasibility study advances.

Alcoa Corporation reported a net income of $232 million for Q3 2025, driven by strategic asset sales and operational milestones including the permanent closure of its Kwinana alumina refinery and the sale of its Saudi Arabia joint venture stake.

Immutep Limited reports strong progress in its Phase III lung cancer trial with over 170 patients enrolled, alongside positive FDA feedback and a robust cash position supporting ongoing development.

Voltaic Strategic Resources has identified new gold mineralised corridors at Meekatharra and confirmed rare earth potential at Paddys Well, while maintaining a robust cash position of A$7.9 million.

Renergen Limited forecasts a significant rise in loss per share for H1 2025, driven by one-off transaction costs and full commissioning expenses. The company’s updated trading statement reveals losses could nearly double compared to last year.

Australasian Metals Limited advances exploration at its May Queen Gold Project with promising geophysical survey results and plans for a significant drilling campaign, while maintaining a robust financial footing.

Medibank has set ambitious goals to triple its health segment earnings by FY30, expand its private health insurance market share, and double its health engagement, signaling a strategic pivot towards integrated, technology-driven care.

NZME Limited has upgraded its FY25 Operating EBITDA guidance, signaling stronger-than-expected financial performance despite economic headwinds. The company now expects earnings between $59 million and $62 million, up from its earlier forecast.